2-(3,5-Dichlorophenoxy)ethanamine hydrochloride, 100mg

Objectif IOS plan PL-M 20x/0.40 corrigé à l'infini. Distance de travail 7,8 mm. Pas de correction du verre de protection

(Z)-Octadec-13-en-1-yl acetate, 90%, 100mg

2-Methyl-1-(4-(methylthio)phenyl)-2-morpholinopropan-1-one, 98.0%, 5g

Succinylsulfathiazole, 98.0%, 1g

1-methyl-3-octyl-1H-imidazol-3-ium hydrogen sulfate, 500g

3-methyl-1-(4-phenyl-1,3-thiazol-2-yl)-1H-pyrazol-5-amine, 95.0%, 250mg

N-(4-(N-(5-Methylisoxazol-3-yl)sulfamoyl)phenyl)acetamide, 95.0%, 250mg

4-Bromoimidazo[4,5-c]pyridine, 95.0%, 250mg

N-(2-(tert-butyl)phenyl)benzamide, 98%, 25mg

4-Aminopicolinamide, 95.0%, 10g

tert-Butyl ((2S,3S)-1-(4-(benzyloxy)phenyl)-4-chloro-3-hydroxybutan-2-yl)carbamate, 98+%, 100mg

n-Cyclohexyl-1,3-benzothiazol-2-amine, 98%, 250mg